Loading Complete
Edward W Gabrielson

Edward W Gabrielson, MD

Clinical and Laboratory Pathology

Highlights

Languages

  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Edward W Gabrielson

Professional Titles

  • Attending Pathologist, Johns Hopkins Hospital
  • Attending Pathologist, Johns Hopkins Bayview Medical Center

Primary Academic Title

Professor of Pathology

Johns Hopkins Physician

Logo for Johns Hopkins Physician

Background

Dr. Edward W. Gabrielson is a Professor of Pathology and Oncology at the Johns Hopkins University School of Medicine and Professor of Environmental Health Engineering at the Johns Hopkins Bloomberg School of Public Health. He specializes in molecular pathology, with particular emphasis on the pathology of breast, esophageal and lung cancers. Dr. Gabrielson is a member of the Johns Hopkins Kimmel Cancer Center.

He received his M.D. from Northwestern University, completed a residency in pathology at the University of Colorado School of Medicine, followed by a fellowship in pathology at the National Institutes of Health.

Dr. Gabrielson has authored or co-authored approximately 200 peer-reviewed publications.

Additional Academic Titles

Professor of Oncology

Research Interests

Biomarkers, Breast cancer, Esophageal cancer, Lung cancer

Research Summary

Dr. Gabrielson investigates the molecular biology of breast cancer and lung cancer, emphasizing aspects that have potential clinical significance. Current areas of emphasis include molecular classification of cancers, genetic instability in cancer, and functional changes in cancers related to cell-cell interactions and cellular metabolism.

Selected Publications

  • Daniel J, Coulter J, Woo JH, Wilsbach K, Gabrielson E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci U S A; 108: 5384-9, 2011

  • Gniadek TJ, Li QK, Tully E, Chatterjee S, Nimmagadda S, Gabrielson E. Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy. Mod Pathol. 2017;30:530-53

  • Jhaveri TZ, Woo J, Shang X, Park BH and Gabrielson E. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget. 2015; 6(17):14754-14765

  • Lemmon, C. R., Woo, J. H., Tully, E., Wilsbach, K., and Gabrielson, E. Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. J Biol Chem, 286: 31457-31465, 2011

  • Li QK, Singh A, Biswal S, Askin F, Gabrielson E. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma. J Hum Genet; 56: 230-4, 2011

Graduate Program Affiliations

  • Pathology

    Cellular and Molecular Medicine

Memberships

  • United States and Canadian Academy of Pathology
  • International Association for the Study of Lung Cancer
  • Lungevity Foundation

Locations

  1. Johns Hopkins Bayview Medical Center
  2. The Johns Hopkins Hospital

Expertise

Education

  • Fellowship: National Institutes of Health, Pathology, 1985
  • Residency: University of Colorado School of Medicine, Pathology, 1982
  • Medical Education: Northwestern University School of Medicine, MD, 1977

Board Certifications

  • Anatomic Pathology: American Board of Pathology, 1983
  • Clinical Pathology: American Board of Pathology, 1983

Insurance

Please contact the location directly to confirm your health plan is accepted.
Search plans
  • Aetna
  • CareFirst
  • Cigna
  • First Health
  • Geisinger Health Plan
  • HealthSmart/Accel
  • Johns Hopkins Health Plans
  • MultiPlan
  • Pennsylvania's Preferred Health Networks (PPHN)
  • Point Comfort Underwriters
  • Private Healthcare Systems (PHCS)
  • Veteran Affairs Community Care Network (Optum-VACCN)